COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,812 Articles (21,985 medRxiv, 7,827 bioRxiv)

Most recent first Previous |  Page 2772: Articles 27711-27720  | Next

Clinical Characteristics of 20,662 Patients with COVID-19 in mainland China: A Systemic Review and Meta-analysis
Tang, C., Zhang, K., Wang, W., Pei, Z., Liu, Z., Yuan, P., Guan, Z., Gu, J.
10.1101/2020.04.18.20070565 — Posted: 2020-04-23
A single-cell atlas of the peripheral immune response to severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martinez-Colon, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., Simpson, L. J., Grant, P., Subramanian, A., Rogers, A. J., Blish, C. A.
10.1101/2020.04.17.20069930 — Posted: 2020-04-23 Discussion: Onsite | Offsite
Distinguish Coronavirus Disease 2019 Patients in General Surgery Emergency by CIAAD Scale: Development and Validation of a Prediction Model Based on 822 Cases in China
Zhao, B., Wei, Y., Sun, W., Qin, C., Zhou, X., Wang, Z., Li, T., Cao, H., Wang, W., Wang, Y.
10.1101/2020.04.18.20071019 — Posted: 2020-04-23
First study on mental distress in Brazil during the COVID-19 crisis
Zhang, S. X., Wang, Y., Afshar Jahanshahi, A., Jia, J., Haensel Schmitt, V. G.
10.1101/2020.04.18.20070896 — Posted: 2020-04-23
Exit strategies: optimising feasible surveillance for detection, elimination and ongoing prevention of COVID-19 community transmission
Lokuge, K., Banks, E., Davis, S., Roberts, L., Street, T., O'Donovan, D., Caleo, G., Glass, K.
10.1101/2020.04.19.20071217 — Posted: 2020-04-23 Discussion: Onsite
Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
Ortiz Bezara, M. E., Thurman, A., Pezzulo, A., Leidinger, M. R., Klesney-Tait, J. A., Karp, P. H., Tan, P., Wohlford-Lenane, C., McCray, P. B., Meyerholz, D. K.
10.1101/2020.04.22.056127 — Posted: 2020-04-23 Discussion: Onsite
Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2
Heiser, K., McLean, P. F., Davis, C. T., Fogelson, B., Gordon, H. B., Jacobson, P., Hurst, B. L., Miller, B. J., Alfa, R. W., Earnshaw, B. A., Victors, M. L., Chong, Y. T., Haque, I. S., Low, A. S., Gibson, C. C.
10.1101/2020.04.21.054387 — Posted: 2020-04-23
Preliminary support for a 'dry swab, extraction free' protocol for SARS-CoV-2 testing via RT-qPCR
Srivatsan, S., Han, P. D., van Raay, K., Wolf, C. R., McCulloch, D. J., Kim, A. E., Brandstetter, E., Martin, B., Gehring, J., Chen, W., Seattle Flu Study Investigators, , Kosuri, S., Konnick, E. Q., Lockwood, C. M., Reider, M. J., Nickerson, D. A., Chu, H. Y., Shendure, J., Starita, L. M.
10.1101/2020.04.22.056283 — Posted: 2020-04-23
Structural and biochemical characterization of nsp12-nsp7-nsp8 core polymerase complex from COVID-19 virus
Peng, Q., Peng, R., Yuan, B., Zhao, J., Wang, M., Wang, X., Wang, Q., Sun, Y., Fan, Z., Qi, J., Gao, G. F., Shi, Y.
10.1101/2020.04.23.057265 — Posted: 2020-04-23
Functional and Genetic Analysis of Viral Receptor ACE2 Orthologs Reveals Broad Potential Host Range of SARS-CoV-2
Liu, Y., Hu, G., Wang, Y., Zhao, X., Ji, F., Ren, W., Gong, M., Ju, X., Li, C., Hong, J., Zhu, Y., Cai, X., Wu, J., Lan, X., Xie, Y., Wang, X., Yuan, Z., Zhang, R., Ding, Q.
10.1101/2020.04.22.046565 — Posted: 2020-04-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).